Corporate Tech Investors

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund is a corporate VC that makes strategic investments in firms that align with the company's business objectives.

Venture Investor Overview

Venture Investor
Merck Global Health Innovation Fund
Status
Active
Investor Type
Corporate
Activity Level
Funds Raised
Industry Focus
Artificial Intelligence
Biopharmaceutical
Enterprise IT
Healthcare IT
Healthcare Services
Internet & IoT
Medical Devices & Instruments
Software
Transportation

Contact Information

Contact
Joel Krikston
Title
Managing Director
Mailing Address
1 Merck Dr. P.O. Box 100
Whitehouse Station, NJ 08889
USA
Email Address
Not Recorded

Background Information

Overview
By investing in breakthrough health care innovations that are adjacent to Merck/MSD's core pharmaceuticals and vaccines business, Global Health Innovation (GHI) is at the vanguard of Merck/MSD's broadening focus on health and wellness.
Profile
Merck Global Health Innovation Fund LinkedIn Company Profile
Social Media
Merck Global Health Innovation Fund Company Twitter Account
Company News
Merck Global Health Innovation Fund News
Facebook
Merck Global Health Innovation Fund on Facebook
YouTube
Merck Global Health Innovation Fund on YouTube
Last Transaction
7/1/2024

Transaction History

Our records indicate that Merck Global Health Innovation Fund invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
7/1/2024
Unknown
6/12/2024
$8,000,000
5/23/2024
$33,000,000
12/19/2023
$32,000,000
11/29/2023
$10,000,000
8/29/2023
$43,000,000
7/26/2023
$30,000,000
5/18/2023
$23,000,000
3/23/2023
$10,000,000
12/13/2022
$30,000,000
7/28/2022
$35,000,000
3/4/2022
$14,000,000
2/16/2022
$56,000,000
2/14/2022
$45,000,000
1/26/2022
$10,750,000
1/25/2022
$150,000,000
1/19/2022
$200,000,000
12/21/2021
$98,000,000
12/21/2021
$100,000,000
10/13/2021
Unknown
7/29/2021
$90,000,000
6/11/2021
$58,000,000
5/20/2021
$165,000,000
2/26/2021
$30,000,000
11/23/2020
$38,000,000
9/30/2020
$16,000,000
9/16/2020
$50,000,000
9/14/2020
$47,500,000
7/23/2020
$17,000,000
6/2/2020
$30,000,000
5/5/2020
$5,333,000
11/5/2019
$75,000,000
9/18/2019
$26,000,000
7/26/2019
$30,000,000
3/14/2019
$40,000,000
11/21/2018
$11,000,000
5/24/2018
$26,000,000
4/13/2018
$105,000,000
11/30/2017
$70,000,000
11/15/2017
$30,000,000
10/6/2017
$46,700,000
9/26/2017
$25,000,000
9/19/2017
$55,000,000
9/8/2017
$11,000,000
4/14/2017
$12,000,000
1/7/2017
$30,000,000
4/12/2016
$45,000,000
2/29/2016
$35,000,000
2/25/2016
$2,500,000
12/18/2015
$22,000,000
10/28/2015
$10,000,000
10/7/2015
$18,000,000
7/14/2015
$8,000,000
5/28/2015
$25,000,000
4/13/2015
$2,500,000
3/16/2015
Unknown
3/3/2015
$15,500,000
2/9/2015
$14,000,000
12/31/2014
$5,000,000
11/4/2014
$26,500,000
9/18/2014
$9,000,000
7/1/2014
$10,000,000
5/28/2014
$9,300,000
4/9/2014
$12,000,000
12/5/2013
$7,000,000
9/30/2013
Unknown
6/30/2013
$39,999,900
6/18/2013
$15,000,000
3/31/2013
$6,719,200
12/18/2012
$20,000,000
11/14/2012
$6,000,000
9/30/2012
$6,999,900
4/10/2012
$30,000,000
1/6/2012
$17,000,000

 


Investor Contacts

Title
Name
Email & Social
Managing Director
Joel Krikston
  Joel Krikston LinkedIn Profile  Joel Krikston Twitter Account  Joel Krikston News  Joel Krikston on Facebook
Managing Director
David Rubin
  David Rubin LinkedIn Profile  David Rubin Twitter Account  David Rubin News  David Rubin on Facebook
Managing Director
Dave Stevenson
  Dave Stevenson LinkedIn Profile  Dave Stevenson Twitter Account  Dave Stevenson News  Dave Stevenson on Facebook
Managing Director
Bill Taranto
  Bill Taranto LinkedIn Profile  Bill Taranto Twitter Account  Bill Taranto News  Bill Taranto on Facebook
Managing Director
Joe Volpe
  Joe Volpe LinkedIn Profile  Joe Volpe Twitter Account  Joe Volpe News  Joe Volpe on Facebook
Managing Director
Francesca Wuttke
  Francesca Wuttke LinkedIn Profile  Francesca Wuttke Twitter Account  Francesca Wuttke News  Francesca Wuttke on Facebook

 


Funds

No fund closings have been recorded for this company.

 


Portfolio Companies

Merck Global Health Innovation Fund has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more corporate investors:

Merck Capital Ventures | Merck Serono Ventures

 

Share this article

 


About Our Corporate VC Strategic Investors Directory

Our corporate equity investment data comes from VentureDeal.com, a leading provider of corporate tech investing transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary